MARC details
| 000 -CABECERA |
|---|
| campo de control de longitud fija |
06611cam a2200469Ia 4500 |
| 001 - NÚMERO DE CONTROL |
|---|
| campo de control |
96454 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
|---|
| campo de control |
ES-MaUEC |
| 005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN |
|---|
| campo de control |
20230102112754.0 |
| 006 - CÓDIGOS DE INFORMACIÓN DE LONGITUD FIJA--CARACTERÍSTICAS DEL MATERIAL ADICIONAL |
|---|
| campo de control de longitud fija |
m o d |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
cr |n||||||||| |
| 008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
170830s2017 nyu ob 001 0 eng d |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| Número Internacional Estándar del Libro |
3319571532 |
| Información calificativa |
(electronic bk.) |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| Número Internacional Estándar del Libro |
9783319571539 |
| Información calificativa |
(electronic bk.) |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| ISBN cancelado o inválido |
3319571524 |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| ISBN cancelado o inválido |
9783319571522 |
| 040 ## - FUENTE DE LA CATALOGACIÓN |
|---|
| Centro catalogador/agencia de origen |
YDX |
| Lengua de catalogación |
eng |
| Centro/agencia transcriptor |
YDX |
| Centro/agencia modificador |
N$T |
| -- |
EBLCP |
| -- |
GW5XE |
| -- |
N$T |
| -- |
UAB |
| -- |
OCLCF |
| -- |
MERER |
| -- |
YDX |
| -- |
OCLCQ |
| -- |
ESU |
| -- |
IOG |
| -- |
COO |
| -- |
DEBBG |
| -- |
OCLCO |
| -- |
OCLCA |
| -- |
NJR |
| -- |
ES-MaUEC |
| Lengua de catalogación |
spa |
| 050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Número de clasificación |
RM301.37 |
| Número de documento/Ítem |
2017 EB |
| 066 ## - JUEGOS/CONJUNTO DE CARACTERES UTILIZADOS/PRESENTES |
|---|
| Juego/conjunto de caracteres alternativo G0 o G1 |
(S |
| 245 00 - MENCIÓN DE TÍTULO |
|---|
| Título |
Cell therapy : |
| Resto del título |
current status and future directions |
| Mención de responsabilidad, etc. |
Dwaine F. Emerich, Gorka Orive, editors. |
| 264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT |
|---|
| Producción, publicación, distribución, fabricación y copyright |
New York, NY |
| Nombre del de productor, editor, distribuidor, fabricante |
Humana Press |
| Fecha de producción, publicación, distribución, fabricación o copyright |
2017 |
| 300 ## - DESCRIPCIÓN FÍSICA |
|---|
| Extensión |
1 recurso en línea |
| 336 ## - TIPO DE CONTENIDO |
|---|
| Fuente |
rdacontent |
| Término de tipo de contenido |
Texto |
| Código de tipo de contenido |
txt |
| 337 ## - TIPO DE MEDIO |
|---|
| Fuente |
rdamedia |
| Nombre/término del tipo de medio |
electrónico |
| Código del tipo de medio |
c |
| 338 ## - TIPO DE SOPORTE |
|---|
| Fuente |
rdacarrier |
| Nombre/término del tipo de soporte |
recurso electrónico |
| Código del tipo de soporte |
cr |
| 490 0# - MENCIÓN DE SERIE |
|---|
| Mención de serie |
Molecular and translational medicine |
| Número Internacional Normalizado para Publicaciones Seriadas |
2197-7852 |
| 988 ## - NOTA LOCAL 598 |
|---|
| Nota local 598 (boletines) |
Springer_Medicine_2017 |
| 500 ## - NOTA GENERAL |
|---|
| Nota general |
|
| 504 ## - NOTA DE BIBLIOGRAFÍA, ETC. |
|---|
| Nota de bibliografía, etc. |
Incluye referencias bibliográficas e índice |
| 505 0# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
Dedication; Preface: A Brief Introduction to the Span of Cell Therapy; Contents; Contributors; 1: Molecular Considerations in Cell Transplant Imaging; Introduction; The Need for Molecular Imaging: Limitations of Cell-Based Therapies;Recent Advances in Molecular Imaging;Bright-Field and Fluorescent Optical Imaging; PET Imaging; Bioluminescence Imaging; MR Imaging and Spectroscopy; Concluding Remarks and Outlook; References; 2: Considerations for Successful Encapsulated B-cell Therapy; Introduction; Islet Transplantation; Islet Transplantation: Site Selection Considerations |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
Encapsulating Islets: Biomass Considerations Islet Encapsulation Failure Modes;Subacute Processing Stress; Acute Implant Failure; Chronic Failure of Cell Encapsulation Systems; Immune Rejection; Hypoxia; Strategies for Addressing Hypoxia; Refillable Gas Supply; Artificial Oxygen Carriers; Vascularization; Strategies for Mitigating Chronic Fibrosis; Coatings and Covalent Modifications; Stem Cell-Derived B-Cells as an Alternative to Isolated Cadaveric Islets; Generation of Glucoresponsive Stem Cell-Derived B-Cells; Clinical Translation of Stem Cell-Derived B-Cells |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
Increased Inhibition Strategies Limits of This Approach; Cell Therapy: Encapsulated Cell Biodelivery (ECB) Systems; Introduction: Description of the Strategy; Increased Inhibition Strategies: Galanin; Neurotrophic Factors; Delivering NTF with ECB Devices; References; 6: Dendritic Cell-Based Cancer Therapies: Current Status and Future Directions; Introduction; Dendritic Cell Subpopulations; Plasmacytoid Dendritic Cells; Conventional/Myeloid Dendritic Cells; Skin Dendritic Cells; Inflammatory DCs; Dendritic Cell Functions; Activating Signals from DCs; Inhibitory Signals from DCs |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
TBI and Stroke: Implications of Cell-Free Treatment Feasibility of Exosome Transplantation Therapies; Conclusion: Connecting the Dots of Stem Cell Therapy; References; 4: Cell Replacement Strategies for Parkinson's Disease; Introduction; Ventral Mesencephalon Grafting; Clinical Trial Outcomes; Stem Cell Grafting; Conclusions; References; 5: Cell Therapy for Epilepsy; Epilepsy; History; Definitions, Clinical Features, Therapeutic Needs, and Models; Cell Therapy: Direct Grafting; Introduction: Cell Types; Substitution Strategies and Bystander Effects |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
The Future of B-Cell TherapyReferences; 3: Stem Cell Therapy for Neurovascular and Traumatic Brain Diseases; Introduction; Acute Pathology of Stroke and TBI; Chronic Pathology of Stroke and TBI; Stem Cell Therapy for Neurovascular Disorders; Stem Cell Transplantation in Stroke; Stem Cell Transplantation in TBI; Mechanisms of Stem Cell Therapy; The Promise of Combination Therapies with Stem Cells; The Spleen as a Novel Target for Stem Cells; Challenges in Stem Cell Therapy; Potential Adverse Effects of Stem Cell Therapy; Cell-Free Materials and Exosomes in Neurovascular Therapy |
| 520 3# - SUMARIO, ETC. |
|---|
| Sumario, etc. |
This volume provides a comprehensive, state-of-the art review of the field of cell therapy. The volume begins with an overview of the breadth of the field and then turns to overviews of imaging technologies that can aid in both safety and efficacy evaluations. The book then turns to numerous contributions detailing the rapidly growing field of stem cell therapies. These sections cover our understanding of the natural roles of stem cells in biology and human disease and then touches on several of the more prominent areas where stem cells are moving rapidly into clinical evaluation including neurodegenerative diseases, muscular dystrophy, cardiac repair, and diabetes. The volume concludes with contributions from experts in oncology, ophthalmiology, stem cells, 3-D printing, and biomaterials where the convergence of expertise is leading to unprecedented insights into how to minutely control the in vivo fate and function of transplanted and/or endogeneously mobilized cells. Finally, the book provides insights into the pivotal relationship between academic and industrial partnerships. This volume is designed to touch on the major areas where the field will make its greatest and most immediate clinical impacts. This text will provide a useful resource for physicians and researchers interested in the rapidly changing filed of cell therapy. |
| 650 #7 - PUNTO DE ACCESO ADICIONAL DE MATERIA--TÉRMINO DE MATERIA |
|---|
| Término de materia o nombre geográfico como elemento de entrada |
Drogas |
| Subdivisión general |
Efectos fisiológicos |
| Fuente del encabezamiento o término |
embne |
| Número de control del registro de autoridad o número normalizado |
(OCoLC)fst00850322 |
| 9 (RLIN) |
169030 |
| 700 1# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA |
|---|
| Nombre de persona |
Emerich, Dwaine F. |
| 700 1# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA |
|---|
| Nombre de persona |
Orive, Gorka. |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
|---|
| Identificador Uniforme del Recurso |
https://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57153-9 |
| Nota pública |
Acceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 880 0# - REPRESENTACIÓN GRÁFICA ALTERNATIVA |
|---|
| Enlace |
505-00 |
| a |
Molecular Considerations in Cell Transplant Imaging -- Considerations for Successful Encapsulated β Cell Therapy -- Stem Cell Therapy for Neurovascular and Traumatic Brain Diseases -- Cell Replacement Strategies for Parkinson's Disease -- Cell Therapy for Epilepsy -- Dendritic Cell-Based Cancer Therapies: Current Status and Future Directions -- Encapsulation Approaches to Cell Therapy -- Biomaterials and Cells for Re-Vascularization -- Cell Reprogramming for Cardiac Regeneration and Rare Disease Modeling -- Engineering Organoid Systems to Model Health and Disease -- 3D Printing for Cell Therapy Applications -- Cell Therapy for Ophthalmic Diseases -- Cell Therapy: Approaching a Partnership with Pharma -- Stem Cell Therapy in Duchenne Muscular Dystrophy. |
| 999 ## - NÚMEROS DE CONTROL DE SISTEMA (KOHA) |
|---|
| -- |
1 |
| 942 ## - ELEMENTOS DE PUNTO DE ACCESO ADICIONAL (KOHA) |
|---|
| Fuente del sistema de clasificación o colocación |
Library of Congress Classification |
| Tipo de ítem Koha |
LIBRO-E NO PRÉSTAMO |
| 998 ## - DATOS ESTADÍSTICOS |
|---|
| Fecha de catalogación |
02/2018 |
| Tipo de materia |
E-book |
| Catalogador |
|
| Catalogado |
Sí |